514 related articles for article (PubMed ID: 29405465)
1. Intravenous fentanyl use among people who inject drugs in Australia.
Geddes L; Iversen J; Memedovic S; Maher L
Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S314-S322. PubMed ID: 29405465
[TBL] [Abstract][Full Text] [Related]
2. High risk injecting behaviour among people who inject pharmaceutical opioids in Australia.
Iversen J; Dertadian G; Geddes L; Maher L
Int J Drug Policy; 2017 Apr; 42():1-6. PubMed ID: 28104570
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and correlates of multiple non-fatal opioid overdoses among people who inject drugs who utilise needle syringe programs in Australia.
Geddes L; Iversen J; Darke S; Dietze P; Maher L
Int J Drug Policy; 2021 Oct; 96():103245. PubMed ID: 33840562
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.
Bazazi AR; Zelenev A; Fu JJ; Yee I; Kamarulzaman A; Altice FL
Int J Drug Policy; 2015 Jul; 26(7):675-81. PubMed ID: 25532449
[TBL] [Abstract][Full Text] [Related]
5. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs.
Lake S; Hayashi K; Buxton J; Milloy MJ; Dong H; Wood E; Montaner J; Kerr T
Drug Alcohol Depend; 2015 Nov; 156():297-303. PubMed ID: 26454837
[TBL] [Abstract][Full Text] [Related]
6. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
[TBL] [Abstract][Full Text] [Related]
7. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD.
Park JN; Weir BW; Allen ST; Chaulk P; Sherman SG
Harm Reduct J; 2018 Jul; 15(1):34. PubMed ID: 29976195
[TBL] [Abstract][Full Text] [Related]
8. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
[TBL] [Abstract][Full Text] [Related]
9. Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs.
Ambekar A; Rao R; Mishra AK; Agrawal A
Drug Alcohol Rev; 2015 Jan; 34(1):97-104. PubMed ID: 25302827
[TBL] [Abstract][Full Text] [Related]
10. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs.
Lambdin BH; Bluthenthal RN; Zibbell JE; Wenger L; Simpson K; Kral AH
Int J Drug Policy; 2019 Dec; 74():299-304. PubMed ID: 31733979
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs.
Blackburn NA; Lancaster KE; Ha TV; Latkin CA; Miller WC; Frangakis C; Chu VA; Sripaipan T; Quan VM; Minh NL; Vu PT; Go VF
Harm Reduct J; 2017 Sep; 14(1):62. PubMed ID: 28882143
[TBL] [Abstract][Full Text] [Related]
12. Purposeful Fentanyl Use and Associated Factors among Opioid-Dependent People Who Inject Drugs.
Chandra DK; Altice FL; Copenhaver MM; Zhou X; Didomizio E; Shrestha R
Subst Use Misuse; 2021; 56(7):979-987. PubMed ID: 33769199
[No Abstract] [Full Text] [Related]
13. Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland.
Buresh M; Gicquelais RE; Astemborski J; Kirk GD; Mehta SH; Genberg BL
PLoS One; 2020; 15(3):e0230127. PubMed ID: 32160244
[TBL] [Abstract][Full Text] [Related]
14. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus prevalence and associated risk factors among Indigenous Australians who inject drugs.
Doyle M; Maher L; Graham S; Wand H; Iversen J
Aust N Z J Public Health; 2018 Feb; 42(1):52-56. PubMed ID: 29168317
[TBL] [Abstract][Full Text] [Related]
16. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015.
Graham S; Maher L; Wand H; Doyle M; Iversen J
Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl self-testing in a community-based sample of people who inject drugs, San Francisco.
Oh H; Kim K; Miller D; Veloso D; Lin J; McFarland W
Int J Drug Policy; 2020 Aug; 82():102787. PubMed ID: 32516685
[TBL] [Abstract][Full Text] [Related]
18. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.
Rivera AV; Nolan ML; Paone D; Carrillo SA; Braunstein SL
Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642
[No Abstract] [Full Text] [Related]
19. Prevalence and correlates of receptive syringe-sharing among people who inject drugs in rural Appalachia.
White RH; O'Rourke A; Kilkenny ME; Schneider KE; Weir BW; Grieb SM; Sherman SG; Allen ST
Addiction; 2021 Feb; 116(2):328-336. PubMed ID: 32533612
[TBL] [Abstract][Full Text] [Related]
20. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
Geddes L; Iversen J; Wand H; Maher L
Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
